Profiel
Christopher Kevil was the founder of TheraVasc, Inc. which was founded in 2008, where he held the title of Chief Scientific Officer from 2008 to 2016.
He also worked as Director-Vascular Biology & Angiogenesis at LSU Health System Health Care Services Division.
Dr. Kevil holds a doctorate degree from Louisiana State University and an undergraduate degree from Northwestern State University.
Eerdere bekende functies van Christopher Kevil
| Bedrijven | Functie | Einde |
|---|---|---|
TheraVasc, Inc.
 TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Oprichter | 01-01-2016 |
| LSU Health System Health Care Services Division | Corporate Officer/Principal | - |
Opleiding van Christopher Kevil
| Louisiana State University | Doctorate Degree |
| Northwestern State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| LSU Health System Health Care Services Division | |
TheraVasc, Inc.
TheraVasc, Inc. Pharmaceuticals: MajorHealth Technology TheraVasc, Inc. operates as a pharmaceutical company. It develops treatments for various chronic medical diseases and drugs for unserved vascular disease markets. The company was founded by Anthony Giordano, Christopher Kevil and James Douglas Boudreaux in 2008 and is headquartered in Cleveland, OH. | Health Technology |
